[et_pb_section fb_built=”1″ next_background_color=”#ffffff” _builder_version=”4.16″ _module_preset=”default” background_color=”#f1592a” custom_padding=”20px||20px||true|false” bottom_divider_style=”wave2″ global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider show_divider=”off” _builder_version=”4.16″ _module_preset=”default” background_enable_color=”off” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Content Section” _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||2px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” header_font=”|600|||||||” global_colors_info=”{}”]<\/p>\n
\n2023 Slides<\/h1>\n<\/blockquote>\n
[\/et_pb_text][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font_size=”16px” header_3_text_align=”center” global_colors_info=”{}”]<\/p>\n
PLEASE NOTE:<\/strong> Materials for all symposia are available for attendees of the live 2023 conferences only and are password-protected. Please consult your meeting welcome email or conference documentation for the password.<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.19.5″ _module_preset=”default” text_font_size=”16px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
\n
- Bergman: Rheumatologic Therapies: Peri-op considerations<\/a><\/li>\n
- Bergman\/Troum: Rheum medley (gout, OA, SS, pSS, vasculitis)<\/a><\/li>\n
- Cush\/Kavanaugh: New Developments in Rheumatoid Arthritis<\/a><\/li>\n
- Cush\/Wells: Rheumatology in 2033- Back to the Future?<\/a><\/li>\n
- Dua: IgG4-Related Disease: what\u2019s new?<\/a><\/li>\n
- Dua: Rheumatology Education \u2013 past, present and future<\/a><\/li>\n
- Fleischmann: X-rays should still be followed in RA and PsA<\/a><\/li>\n
- Fleischmann: SLE \u2013 recent, new and future therapeutics<\/a><\/li>\n
- Kavanaugh: What\u2019s new in Psoriatic Arthritis<\/a><\/li>\n
- Mahadevan: Gastroenterology Update for the Rheumatologist<\/a><\/li>\n
- Martin: How I Do It: Case-based Dermatology\/Rheumatology<\/a><\/li>\n
- Mease: Pain (simple title, complex issue)<\/a><\/li>\n
- Mease: Psoriatic Arthritis \u2013 the evolving story<\/a><\/li>\n
- Postolova: Immunology Update<\/a><\/li>\n
- Postolova: Allergy: New developments for Rheumatologists<\/a><\/li>\n
- Ruderman: Unconventional Rheumatology<\/a><\/li>\n
- Ruderman: What\u2019s new in Spondyloarthritis<\/a><\/li>\n
- Shenoi: New developments in Pediatric Rheumatology<\/a><\/li>\n
- Shenoi: Treatment of JIA; what\u2019s new and what\u2019s coming?<\/a><\/li>\n
- Troum: Sarcopenia, anti-aging, regenerative medicine; rheumatology relevance<\/a><\/li>\n
- Wells: X-rays should still be followed in RA and PsA<\/a><\/li>\n<\/ul>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”10px||10px||true|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”16px” global_colors_info=”{}”]<\/p>\n
\nQuestions?<\/h2>\n<\/blockquote>\n